WORCESTER, Mass., Aug. 21, 2008 (GLOBE NEWSWIRE) (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a product licensing and distribution agreement with ABP-Comercio, Importacao E Exportacao Ltda. (www.abptrade.com.br) for the registration, importation, marketing, distribution, and sale in Brazil of Glucose RapidSpray(tm) (www.glucoserapidspray.com), the Company's proprietary glucose buccal spray product.
